A recent study reports that lupus patients who do not consistently take hydroxychloroquine face a higher risk of developing heart disease. The findings highlight how important regular medication adherence may be for this patient group.
Hydroxychloroquine, the most common treatment for lupus, appears to offer cardiovascular protection when taken as directed. The study suggests that even occasional lapses in use could elevate heart disease risk.
While the exact mechanism is not detailed in the source, the study adds to evidence that consistent treatment is crucial for managing both lupus symptoms and long-term cardiovascular health. Clinicians may need to emphasize adherence to patients.